These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9107274)

  • 1. Hormone replacement therapy and high incidence of breast cancer between mammographic screens.
    Schouten LJ; de Rijke JM; Schlangen JT; Verbeek AL
    Lancet; 1997 Apr; 349(9058):1104. PubMed ID: 9107274
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormone replacement therapy and high incidence of breast cancer between mammographic screens.
    Beral V; Banks E; Reeves G; Wallis M
    Lancet; 1997 Apr; 349(9058):1103-4. PubMed ID: 9107273
    [No Abstract]   [Full Text] [Related]  

  • 3. Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations.
    Verkooijen HM; Koot VC; Fioretta G; van der Heiden M; Schipper ME; Rapiti E; Peeters PH; Peterse JL; Bouchardy C
    Breast Cancer Res Treat; 2008 Feb; 107(3):389-95. PubMed ID: 17431760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales.
    Waller M; Moss S; Watson J; Møller H
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2257-61. PubMed ID: 18006913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Glass AG; Lacey JV; Carreon JD; Hoover RN
    J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of bilateral breast cancer at biennial screening mammography in the Netherlands: a population-based study.
    Setz-Pels W; Duijm LE; Groenewoud JH; Voogd AC; Jansen FH; Hooijen MJ; Louwman MW
    Radiology; 2011 Aug; 260(2):357-63. PubMed ID: 21474705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammographic screening is dramatically changing age-incidence data for breast cancer.
    Hemminki K; Rawal R; Bermejo JL
    J Clin Oncol; 2004 Nov; 22(22):4652-3. PubMed ID: 15542818
    [No Abstract]   [Full Text] [Related]  

  • 8. No major impact of mammography screening on the age specific incidence rates of breast cancer in the Netherlands.
    Verkooijen HM; Fioretta G; van der Heiden M; Koot VC; Bouchardy C
    Int J Cancer; 2006 Dec; 119(12):2988; author reply 2989-90. PubMed ID: 17016822
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of screening for breast cancer on its age-incidence relationships and familial risk.
    Hemminki K; Bermejo JL
    Int J Cancer; 2005 Oct; 117(1):145-9. PubMed ID: 15880571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Justifying age thresholds for mammographic screening: an application of pragma-dialectical argumentation theory.
    Schulz PJ; Meuffels B
    Health Commun; 2012; 27(2):167-78. PubMed ID: 21823968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer incidence and hormone replacement therapy in Canada.
    De P; Neutel CI; Olivotto I; Morrison H
    J Natl Cancer Inst; 2010 Oct; 102(19):1489-95. PubMed ID: 20864685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
    Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.
    Autier P; Boniol M; Koechlin A; Pizot C; Boniol M
    BMJ; 2017 Dec; 359():j5224. PubMed ID: 29208760
    [No Abstract]   [Full Text] [Related]  

  • 14. Estimating risk of breast cancer from population incidence affected by widespread mammographic screening.
    Taylor R; Boyages J
    J Med Screen; 2001; 8(2):73-6. PubMed ID: 11480447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico.
    Rosenberg RD; Hunt WC; Williamson MR; Gilliland FD; Wiest PW; Kelsey CA; Key CR; Linver MN
    Radiology; 1998 Nov; 209(2):511-8. PubMed ID: 9807581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of estrogen receptor alpha and progesterone receptor polymorphisms on the effects of hormone therapy on mammographic density.
    van Duijnhoven FJ; Peeters PH; Warren RM; Bingham SA; Uitterlinden AG; van Noord PA; Monninkhof EM; Grobbee DE; van Gils CH
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):462-7. PubMed ID: 16537702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
    Robbins AS; Clarke CA
    J Natl Cancer Inst; 2007 Dec; 99(23):1815; author reply 1816-7. PubMed ID: 18042938
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006.
    Séradour B; Allemand H; Weill A; Ricordeau P
    Bull Cancer; 2009 Apr; 96(4):E1-6. PubMed ID: 19435691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital versus screen-film mammography: impact of mammographic density and hormone therapy on breast cancer detection.
    Chiarelli AM; Prummel MV; Muradali D; Shumak RS; Majpruz V; Brown P; Jiang H; Done SJ; Yaffe MJ
    Breast Cancer Res Treat; 2015 Nov; 154(2):377-87. PubMed ID: 26518019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rationale for starting breast cancer screening under age 50.
    van Schoor G; Broeders MJ; Paap E; Otten JD; den Heeten GJ; Verbeek AL
    Ann Oncol; 2008 Jun; 19(6):1208-9. PubMed ID: 18448450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.